Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Colorectal Neoplasms

Free Subscription 09.11.2026 1 Ann Surg Oncol 3 BMC Cancer 3 BMC Gastroenterol 1 Br J Cancer 1 Cancer 1 Curr Treat Options Oncol 1 Dis Colon Rectum 2 Int J Cancer 2 Int J Colorectal Dis 1 Int J Oncol 3 J Surg Oncol 1 Minerva Gastroenterol (Torino) 4 Oncogene

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. VAN KESTEREN LJ, Aalbers AGJ, Chakroun A, van der Snee L, et al
   ASO Visual Abstract: Long-term Survival After CRS-HIPEC for Colorectal Cancer Peritoneal Metastases.
   Ann Surg Oncol. 2026 Nov 5. doi: 10.1245/s10434-026-20843.
   PubMed        
   
   

   
   BMC Cancer

2. YINGCHEN W, Yinhang W, Jing Z, Jian C, et al
   NaB-induced inhibition of HDAC4 and TUG1: a novel strategy for reversing oxaliplatin resistance in colorectal cancer.
   BMC Cancer. 2026;26:1341.
   PubMed         Abstract available
   
   
3. LANG J, Zhu X, Chen Q, Fu B, et al
   Synergistic induction of pyroptosis-like cell death in colorectal cancer cells by norcantharidin and low-dose oxaliplatin promotes M1 macrophage polarization.
   BMC Cancer. 2026;26:1356.
   PubMed         Abstract available
   
   
4. CARBONELL C, Ding PQ, Adegbulugbe AA, O'Sullivan DE, et al
   Patient-physician sex concordance and real-world disparities in cancer treatment practices and outcomes in medical oncology.
   BMC Cancer. 2026;26:1355.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

5. DING H, Yuan B, Sun G, Yu G, et al
   Conformal sphincter preservation operation versus modified Bacon operation for ultralow rectal cancer: a multicenter retrospective study using propensity-score matching and inverse probability of treatment weighting.
   BMC Gastroenterol. 2026;26:738.
   PubMed         Abstract available
   
   
6. XU PR, Liu ZQ, Tan YF, Wang ZY, et al
   The efficacy and safety of endoscopic resection for multiple rectal neuroendocrine tumors: a retrospective cohort study from a tertiary center.
   BMC Gastroenterol. 2026;26:736.
   PubMed         Abstract available
   
   
7. ZHAO ZX, Yao RD, Hu ZJ, Yao Y, et al
   Exploratory assessment of the clinical significance of the collateral system between the superior mesenteric artery and inferior mesenteric artery in laparoscopic rectal cancer surgery.
   BMC Gastroenterol. 2026;26:730.
   PubMed         Abstract available
   
   

   
   Br J Cancer

8. HILLSON LVS, McCulloch AK, McMahon RK, Hatthakarnkul P, et al
   Immune and stromal tumour biology associated with neoadjuvant radiotherapy response in locally advanced rectal cancer.
   Br J Cancer. 2026;135:1705-1714.
   PubMed         Abstract available
   
   

   
   Cancer

9. SU D, Li C, Zheng T, Tang J, et al
   Liposomal irinotecan and capecitabine plus bevacizumab as second-line therapy in metastatic colorectal cancer: A multicenter, single-arm study.
   Cancer. 2026;132:e70671.
   PubMed         Abstract available
   
   

   
   Curr Treat Options Oncol

10. XU L, Jiao Y, Wei Y, Luo M, et al
    Synergizing Short-Course Radiotherapy with Immunotherapy in Locally Advanced Rectal Cancer: Current Evidence, Challenges, and Future Directions.
    Curr Treat Options Oncol. 2026;27:55.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

11. RADEMAKER E, Hochstenbach I, van der Woude JM, Kok NFM, et al
    Differences in Presentation and Prognosis of Early versus Late Diagnosis of Locoregional Recurrences after Colon Cancer Resection: A Nationwide Cohort Study.
    Dis Colon Rectum. 2026 Nov 3. doi: 10.1097/DCR.0000000000004528.
    PubMed         Abstract available
    
    

    
    Int J Cancer

12. ROZEMEIJER K, Claesen J, Dias Goncalves Lima F, Hesselink AT, et al
    Toward Objective Anal Cancer Screening: From Swab-Based Genome-Wide Methylation Marker Discovery to Novel Test Development.
    Int J Cancer. 2026 Aug 27. doi: 10.1002/ijc.70708.
    PubMed         Abstract available
    
    
13. LI J, Yin X, Zhao G, Liu X, et al
    Fruit and Vegetable Intake in Relation to the Risks of Lung, Colorectal, Stomach, and Overall Cancers in China: A Prospective Cohort Study.
    Int J Cancer. 2027;160:98-109.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

14. GUMUS S
    Beyond the LARS score: functional burden does not necessarily equal psychological burden.
    Int J Colorectal Dis. 2026;41:178.
    PubMed         Abstract available
    
    
15. WANG C, Fan H, Yuan J, Zhu X, et al
    Reliability and validity of the modified chinese version of new Cleveland clinic colorectal cancer quality of life questionnaire.
    Int J Colorectal Dis. 2026;41:177.
    PubMed         Abstract available
    
    

    
    Int J Oncol

16. DU K, Wang P, Yang X, Lu Y, et al
    PLD2 fuels 5?fluorouracil resistance in colorectal cancer: Hypoxic hijacking of autophagy unveils a novel therapeutic vulnerability.
    Int J Oncol. 2026;69:140.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

17. DOMINGUEZ-PRIETO V, Olivera-Salazar R, Leon-Arellano M, Vega-Clemente L, et al
    SEPTIN9 Gene Methylation Ratio as Follow-Up Biomarker in Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
    J Surg Oncol. 2026;134:822-829.
    PubMed         Abstract available
    
    
18. MOROCHO B, Morocho C, Bertsch D, Cagir B, et al
    Age-Associated Morbidity After Major Hepatectomy for Colorectal Liver Metastases.
    J Surg Oncol. 2026;134:840-849.
    PubMed         Abstract available
    
    
19. SHERWANI M, Ali D, Lee H, Hawkins AT, et al
    Factors Associated With Receipt of Adjuvant Radiation in Locally Advanced Rectal Cancer.
    J Surg Oncol. 2026;134:904-913.
    PubMed         Abstract available
    
    

    
    Minerva Gastroenterol (Torino)

20. OSMAN MH, Wang Q
    The role of gut microbiota on the tumor microenvironment in colorectal cancer: a systematic review and meta-analysis.
    Minerva Gastroenterol (Torino). 2026 Nov 4. doi: 10.23736/S2724-5985.26.03961.
    PubMed         Abstract available
    
    

    
    Oncogene

21. LONG Y, Li X, Zhu Y, Shen Y, et al
    Therapy-induced tumour senescence drives oxaliplatin resistance via ADORA1-dependent palmitic acid metabolic reprogramming in colorectal cancer.
    Oncogene. 2026 Nov 3. doi: 10.1038/s41388-026-04024.
    PubMed         Abstract available
    
    
22. LIU W, Li H, Ma X, Wang Y, et al
    SIRT3 deficiency triggers mitochondrial dysfunction-associated senescence to suppress colorectal cancer progression via SLC25A13 acetylation.
    Oncogene. 2026 Oct 31. doi: 10.1038/s41388-026-04037.
    PubMed         Abstract available
    
    
23. YANG G, Liu Z, Zhao X, Yu A, et al
    KDM1A promotes colorectal cancer progression by regulating NRP2 and VEGFA-related signaling.
    Oncogene. 2026 Oct 31. doi: 10.1038/s41388-026-04038.
    PubMed         Abstract available
    
    
24. WANG XX, Wang XH, Fan ZH, Ding XF, et al
    TFAM loss drives oxaliplatin resistance by linking mtDNA release to STING-TBK1-mediated lysophagy.
    Oncogene. 2026;45:4875-4887.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum